Search for: "United States v. Abbott Laboratories" Results 21 - 40 of 152
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 May 2012, 9:26 pm by FDABlog HPM
Butler – Abbott Laboratories (“Abbott”) recently submitted a citizen petition to FDA regarding biosimilars under the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”). [read post]
23 Aug 2021, 2:12 am by Radhi Shah (USC Gould School of Law)
Congress, to exercise March-in rights for patents owned by Abbott laboratories, Inc. [read post]
19 Oct 2011, 11:27 am by Dennis Crouch
In 2005, the Court granted certiorari on related issues in Laboratory Corp. of America v. [read post]
17 Feb 2009, 8:05 am
  In another case, the United States Court of Appeals for the Ninth Circuit upheld application of the Noerr-Pennington doctrine in Kaiser Health Foundation, Inc. v. [read post]
24 May 2017, 8:36 am by Steven Cohen
 ABBOTT LABORATORIESUnited States District Court – Eastern District of new York – May 22nd, 2017) involves the drug Depakote. [read post]
24 May 2017, 8:36 am by Steven Cohen
 ABBOTT LABORATORIESUnited States District Court – Eastern District of new York – May 22nd, 2017) involves the drug Depakote. [read post]
1 Feb 2012, 11:15 am by Sean Wajert
Abbott Laboratories, et al., No. 2:10-cv-03242 (E.D. [read post]
26 Jun 2014, 4:00 am by Howard Friedman
Abbott Laboratories, (9th Cir., June 24, 2014), the court reported that the call for en banc review did not receive a majority vote. [read post]
28 Nov 2022, 4:45 pm by Samuel Bray
Professor Harrison's work was recently highlighted by Professor Amanda Frost at SCOTUSBlog as one side of a debate critical to United States v. [read post]